Hints and tips:
Related Special Reports
...Illumina’s market capitalisation is roughly $33bn, about a quarter of Amgen’s and well below Pfizer’s $246bn valuation....
...Rivals AstraZeneca, Johnson & Johnson, Russia’s Sputnik V and new entrants such as Novavax make up the remainder of the market, which is forecast to double in value to $124bn next year....
...Francis Collins, NIH director, told Reuters news agency on Wednesday that Moderna had made a “serious mistake” in not providing co-inventorship credit to people who played a major role in developing a vaccine...
...Snape said another mouse study combining the AstraZeneca and Pfizer vaccines in a course had also been “encouraging”....
...The AU will pay $6.75 a dose for the BioNTech/Pfizer vaccine and $10 for Johnson & Johnson’s, a single-dose product....
...with blood cancer, found researchers at King’s College London and the Francis Crick Institute....
...Francis Collins, the head of the National Institutes of Health, said on Sunday: “I would like to plead to people who are listening to this, this morning, to really hit the reset button on whatever they think...
...After such strong reads from the first two releases (three if we count Russia’s Sputnik V), the disappointing AZN figures were perhaps bound to prompt downward pressure on the company’s shares....
...In August, Russia became the first country to approve a Covid-19 vaccine — named Sputnik V — for civilian use, but western experts cast doubt on its efficacy and safety....
...“If your first dose is the Pfizer vaccine you should not be given the AstraZeneca vaccine for your second dose and vice versa....
...The case involved Francis Lorenzo, an employee at a broker-dealer in Staten Island, New York....
...It was at the Arms Park in 1973 that Gareth Edwards scored a try for the Barbarians v the All Blacks, which experts say has never been matched....
...Illumina president Francis deSouza says better diagnostics can save lives and money. “Treating cancer at stage one is much cheaper than treating it late.”...
...Allergan, the largest specialty pharma group, has said it will refrain from large deals ahead of its takeover by Pfizer....
...One of Francis Bacon’s screaming popes might encapsulate how investors feel about an 82 per cent drop in full-year pre-tax profits to £51m....
...From Alexander Fleming’s discovery of penicillin to the modelling of DNA by Francis Crick and James Watson, Britain’s scientists and pharmaceutical companies have been at the forefront of the life sciences...
...The possibility of a Pfizer/AstraZeneca deal still has the politicians talking (the chief executives of both were hauled before the UK parliament this week)....
...It mirrors similar efforts to refocus and cut costs in research by rival large pharmaceutical companies, including GlaxoSmithKline, Pfizer, Novartis, AstraZeneca and Merck....
...Pfizer’s decision earlier this year to close its UK research facility was a wake-up call that reputation alone will not guarantee Britain’s advantages....
...beyondbrics India v China: a new race in biopharmaceuticals, beyondbrics...
...“There are now these deep pockets of capital available which private companies can take advantage of while their revenue model continues to evolve,” says Stuart Francis, vice-chairman of Barclays Capital...
...However, the language in the announcement and the lack of detail suggests the programme has been delayed and possibly cut back, said Francis Tusa of Defence Analysis....
...Pfizer, the largest US drugmaker by market value, inched down 0.7 per cent to $14.54 as the stock being removed from the “conviction buy” list at Goldman Sachs....
...Elizabethan England, in particular, became “the age of adventure”, of Walter Raleigh and Francis Drake and the trouncing of the Spanish armada....
...Last week’s US jobs report has knocked investor confidence, and those predicting a V-shaped recovery are finding it harder to justify their positions....
International Edition